ORIGINAL ARTICLES

Epigenetic dysregulation of the DAP kinase/p14/HDM2/p53/Apaf-1 apoptosis pathway in acute leukaemias

C S Chim, W W L Chan and Y L Kwong

Department of Medicine, University of Hong Kong, Queen Mary Hospital, Hong Kong

Correspondence to:
Dr C S Chim, University Department of Medicine, Professorial Block, Queen Mary Hospital, 102 Pokfulam Road, Hong Kong; jcschim{at}hku.hk

Background: Dysregulation of apoptosis is important in carcinogenesis.

Aim and Methods: To analyse the potential inactivation of the DAP kinase/p14/HDM2/p53/Apaf-1 pathway by aberrant promoter methylation in acute leukaemias.

Results: Of five leukaemic lines examined, p14 was unmethylated in Raji, HL60 and U937, but completely deleted in Jurkat and NB4. DAP kinase was totally methylated in Raji and NB4, but unmethylated in HL60, Jurkat and U937. Apaf-1 was unmethylated in all the lines. At diagnosis, DAP kinase methylation occurred in eight (25%) APL patients and none of the other AML patients (8/32 vs 0/50, p = 0.001). DAP kinase methylation was detected in four (16%) ALL patients. p14 and Apaf-1 methylation was not detected in any of the 32 cases of acute promyelocytic leukaemia (APL), 50 cases of other subtypes of acute myeloid leukaemia (AML), and 25 cases of acute lymphoblastic leukaemia.

Conclusion: Among AML subtypes, DAP kinase is preferentially hypermethylated in APL.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

• Agirre, X., Vilas-Zornoza, A., Jimenez-Velasco, A., Martin-Subero, J. I., Cordeu, L., Garate, L., San Jose-Eneriz, E., Abizanda, G., Rodriguez-Otero, P., Fortes, P., Rifon, J., Bandres, E., Calasanz, M. J., Martin, V., Heiniger, A., Torres, A., Siebert, R., Roman-Gomez, J., Prosper, F. (2009). Epigenetic Silencing of the Tumor Suppressor MicroRNA Hsa-miR-124a Regulates CDK6 Expression and Confers a Poor Prognosis in Acute Lymphoblastic Leukemia. Cancer Res. 69: 4443-4453 [Abstract] [Full Text]